SCHEMBL19738331

SCHEMBL19738331

CCCC(C)(C)c1cccc2ncsc12

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22430427 0.84 ALDH1A1 (0.32) ALDH1A1HSD17B10
SCHEMBL761996 0.80 ALDH1A1 (0.41) ALDH1A1HSD17B10
SCHEMBL10840507 0.73 ALDH1A1 (0.41) ALDH1A1HSD17B10
SCHEMBL18719874 0.71 MAPT (0.44) ALDH1A1
SCHEMBL25846907 0.70 ELANE (0.38) ALDH1A1HSD17B10
SCHEMBL7627951 0.70 ALDH1A1 (0.38) ALDH1A1HSD17B10
SCHEMBL22326626 0.70 MTNR1A (0.40)
SCHEMBL763959 0.69 ALDH1A1 (0.41) ALDH1A1HSD17B10
SCHEMBL20306283 0.69 ALDH1A1 (0.37) ALDH1A1HSD17B10
SCHEMBL24663443 0.69 PARP1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002323-A1 PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES KREOS CAPITAL VII (UK) LIMITED (GB) 2023-01-05 US disclosed
US-10738010-B2 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides AKEBIA THERAPEUTICS, INC. (US) 2020-08-11 US disclosed
US-10246416-B2 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides AKEBIA THERAPEUTICS, INC. (US) 2019-04-02 US disclosed
US-20170362178-A1 PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES KREOS CAPITAL VII (UK) LIMITED (GB) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362178-A1 PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES HPD, APEH, P4HA1 ALDH1A1 28/4885HSD17B10 204/4885
US-10738010-B2 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides HPD, APEH, P4HA1 ALDH1A1 28/4885HSD17B10 201/4885
US-20230002323-A1 PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES HPD, APEH, P4HA1 ALDH1A1 28/4885HSD17B10 201/4885
US-10246416-B2 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides HPD, APEH, P4HA1 ALDH1A1 28/4885HSD17B10 201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.